Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotox

Author:  ["Cecile King","Regula Mueller Hoenger","Mary Malo Cleary","Kaja Murali-Krishna","Rafi Ahmed","Ernest King","Nora Sarvetnick"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

The mechanism underlying suppression of immune responses by interleukin-4 (IL-4) has remained unexplained. Here we show that the antigen-presenting dendritic cell is central to counter-regulation of autoimmune disease by IL-4. IL-4 acts at the locus of the dendritic cell to decrease the cytolytic T-cell response, preventing autoimmunity. Stimulation of cytotoxic precursors by antigen pulsed dendritic cells induces their differentiation but the process is blocked by IL-4. IL-4-influenced DC produce distinct effects on CD8+ T cells depending on their state of activation. The molecular basis for this regulation is the alteration of the expression ratio of the costimulatory ligands B7.1/B7.2 on dendritic cells. Our findings demonstrate that B7.2 induces expansion of CD8+ T cells and B7.1 governs their acquisition of cytolytic activity. IL-4 influences the dendritic cell to elicit qualitative differences in T-cell responses, providing the basis for counter-regulation mediated by IL-4.

Cite this article

King, C., Mueller Hoenger, R., Malo Cleary, M. et al. Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses. Nat Med 7, 206–214 (2001). https://doi.org/10.1038/84659

View full text

>> Full Text:   Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotox

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF

Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis